| 201/344 | US=9 / Patologia Ovalle WK, Nahirney PC. Sistemas: sentidos especiais. In: ___. Netter, bases da histologia. Rio de Janeiro: Elsevier, 2008. p. 447-69. ISBN 85-3522803-8. DESENVOVIMENTO DA ORELHA; MEATO ACUSTICO EXTERNO; FUNCAO DA ORELHA MEDIA; FUNCAO DA COCLEA; FUNCAO DA MUCOSA OLFATORIA; FUNCAO DOS CORPUSCULOS GUSTATIVOS; FUNCAO DO RECEPTOR SENSORIAIS CUTANEOS; FUNCAO DO CORPO CORONARIO; INERVACAO DOS FUSOS NEUROMUSCULARES |
| 202/344 | US=90 / Biol/Mol Burgess AW, Garrett TPJ. EGFR signaling networks: EGF receptor family extracellular domain structures and functions. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 3-14. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. ERBB2; ERBB3; ERBB4; 3-DIMENSIONAL ESTRUTURAS; TRANSICOES CONFORMACIONAIS; EPITOPOS DE ANTICORPOS |
| 203/344 | US=90 / Biol/Mol Sorkin A. EGFR signaling networks: internalization and degradation of the EGF receptor. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 47-61. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. EGF; RECEPTOR; ENDOCITOSE; CLATRINA; UBIQUITINACAO; DEGRADACAO; ENDOSSOMO; LISOSSOMA |
| 204/344 | US=90 / Biol/Mol Domin J. EGFR signaling networks: phosphoinositide 3-kanase enzymes as downstrem targets of the EGF receptor. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 97-117. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. AKT; FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR; QUINASE; FOSFATIDILINOSITOL; TRANSDUCAO DE SINAL; CELULA; CANCER; MITOGENESE; APOPTOSE; ENDOCITOSE |
| 205/344 | US=90 / Biol/Mol Pritchard JE, Jablonski AB, Parsons SJ. EGFR signaling networks: convergence of EGF receptor and Src family signaling networks in cancer. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 119-37. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. |
| 206/344 | US=90 / Biol/Mol Carraway KL, Yen L, Ingalla E, Sweeney C. EGFR signaling networks: negative regulation of signaling by the EGFR family. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 169-86. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. RECEPTOR EGF; CANCER DE MAMA; ERBB2; REGULADOR NEGATIVO; UBIQUITINA LIGASE E3; CAMUNDONGOS TRANSGENICOS |
| 207/344 | US=90 / Biol/Mol Lao HJ, Carpenter G. EGFR signaling networks: nuclear ErbB receptors: pathways and functions. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 187-97. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. ERBB; FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; NUCLEO; SINALIZAR; TRANSDUCAO |
| 208/344 | US=90 / Biol/Mol Blagoev B, Kratchmarova I, Olsen JV, Mann M. EGFR signaling networks: temporal dynamics of EGF receptor signaling by quantitative proteomics. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 199-207. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; NUCLEO; SINALIZAR; TRANSDUCAO |
| 209/344 | US=90 / Biol/Mol Johnson CG, McIntyre E, Gullick W. EGFR signaling networks: computational and mathematical modeling of the EGF receptor system. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 209-18. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. |
| 210/344 | US=90 / Biol/Mol Bennett HL, Brummer T, Timpson P, Patterson KI, Daly RJ. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: signaling by the EGF receptor in human cancers: accentuate the positive, eliminate the negative. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 235-55. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. SRC; RAS; RAF; ERK; PI3-QUINASE; PTEN; EGFR INIBIDORES; LOOPS DE FEEDBACK; C-CBL; ENDOCITOSE |
| 211/344 | US=90 / Biol/Mol Eberhard DA. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: EGFR mutations, other molecular alterations related to sensitivity to EGFR-targeted therapies in non-small cell lung cancer. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 293-336. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; INIBIDORES DE QUINASE DE TIROSINA; DIAGNOSTICOS MOLECULARES; MUTACOES; HIBRIDACAO IN SITU FLUORESCENTE; IMUNOHISTOQUIMICA; CANCER DE PULMAO |
| 212/344 | US=90 / Biol/Mol Dannenberg AJ, Subbaramaiah K. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: crosstalk between COX-2 and EGFR: apontential therapeutic opportunity. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 337-51. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. CICLOOXIGENASE-2; PROSTAGLANDINAS; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; CROSSTALK; CANCER |
| 213/344 | US=90 / Biol/Mol Thomson S, Haley JD, Yauch R. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: cellular sensitivity to EGF receptor inhibitors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 353-68. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. EGFR; HER2; HER3; ERLOTINIB; A TRANSICAO EPITELIAL MESENQUIMAL; INIBIDORES DE QUINASE DE TIROSINA |
| 214/344 | US=1 / Química Harnett MM, Goodridge HS. Crescimento celular, diferenciação e câncer. In: Baynes JW, Dominiczak MH. Bioquímica médica. 2ª ed. Rio de Janeiro: Elsevier, 2007. p. 601-17. ISBN 85-3522298-2. CICLO CELULAR; FATORES DE CRESCIMENTO CELULAR; RECEPTOR PDGF; RECEPTOR DE CITOCINA; REGULACAO DO CICLO CELULAR; APOPTOSE; CASPASE; CANCER; ONCOGENE; GENES SUPRESSORES DE TUMOR |
| 215/344 | US=111 / Câncer Willimson KE, El Din OS, O'Kane HF. Apoptosis. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 47-59. ISBN 978-0-470-01852-1. APOPTOSE; EQUILIBRIO SOBREVIVENCIA; CONTROLE GENETICO DA APOPTOSE; VIAS APOPTOTICAS; VIA DO RECEPTOR DE MORTE; RECEPTORES DE MORTE; FAMILIA BCL-2; PERMEABILIDADE MITOCONDRIAL; CASPASE; INIBIDOR DE PROTEINAS DE APOPTOSE; PROTEINAS ANTI-APOPTOTICAS; AVALIACAO DA APOPTOSE |
| 216/344 | US=111 / Câncer Kawasaki BT, Howard OMZ, Gamero AM, Farrar WL. Signalling by cytokines. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 198-211. ISBN 978-0-470-01852-1. CANCER; SINALIZACAO POR CITOCINAS; INTERFERON; FATOR DE NECROSE TUMORAL; RECEPTOR DE QUIMIOCINA; TRANSDUCAO DE SINAL |
| 217/344 | US=111 / Câncer Carraway KL, Carraway CAC. Signalling by tyrosine kinases. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 212-25. ISBN 978-0-470-01852-1. CANCER; SINALIZACAO POR TIROSINA-QUINASES; RECEPTOR TIROSINA-QUINASE |
| 218/344 | US=16 / Urologia Schalken JA. Biology and imaging: prostate (cancer) stem cells. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 63-72. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; CANCER DE PROSTATA; CELULAS-TRONCO; RECEPTOR DE ANDROGENO; CELULAS CANCEROSAS ESTAMINAIS; C-MET PROTOONCOGENE; FATOR DE CRESCIMENTO HEPATOCITO; FATOR DE DISPERSAO; HGF / SF; IMUNOFENOTIPO; QUERATINA 14,5; QUERATINA 18; FATORES NEUROENDOCRINOS; METASTASE; SEROTONINA; CROMOGRANINA A |
| 219/344 | US=16 / Urologia Klocker H, Eder IE, Comuzzi B, Bartsch G, Culig Z. Biology and imaging: androgen receptor function in prostate cancer progression. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 87-105. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; FUNCAO DO RECEPTOR DE ANDROGENO; CANCER DE PROSTATA; AMPLIFICACAO; ABLACAO ANDROGENICA; RECEPTOR DE ANDROGENO; COATIVADORES; LIGANTE DE ATIVACAO INDEPENDENTE; MUTACOES |
| 220/344 | US=16 / Urologia Keller ET. Biology and imaging: biology and therapeutic basis of prostate cancer bone metastasis. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 175-91. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; BASE TERAPEUTICA DE METASTASES OSSEAS; CANCER DE PROSTATA; ENDOTELINA-1; ET-1; IL-6; OPG; OSTEOPROTEGERINA; HORMONIO DA PARATIREOIDE; PTHRP; RANKL; RECEPTOR DO FATOR NUCLEAR-K B |